New data from the Australian Institute of Health and Welfare (AIHW) explores outcomes of mothers and their babies during the early years of the COVID-19 pandemic.
May 8, 2024
0
0
South Carolina received a poor report card from the March of Dimes in 2023 because more of its mothers die due to pregnancy-related complications or childbirth than the national average. For every 100,000 births, there are ...
May 8, 2024
0
0
Neuropathy, the nerve damage that causes pain and numbness in the feet and hands and can eventually lead to falls, infection and even amputation, is very common and underdiagnosed, according to a study published in the May ...
May 8, 2024
0
0
A long-haul flight or an overnight stay in the mountains: For many patients with a Fontan circulation (single-ventricle physiology), this was previously unimaginable, as there was insufficient medical research into how acute ...
May 8, 2024
0
0
Using a computational model representing the full respiratory tract, researchers from the University of Technology Sydney (UTS) have confirmed the safety of CPAP therapy, addressing concerns about potential damage to lung ...
May 8, 2024
0
0
If you didn't have food allergies as a child, is it possible to develop them as an adult? The short answer is yes. But the reasons why are much more complicated.
May 8, 2024
0
2
The COVID-19 pandemic significantly increased interest in wearable health-monitoring devices among low-income Hispanic and Latine adults living in the U.S., a new Northwestern University study has found.
May 8, 2024
0
0
Researchers have discovered a protein marker to help identify cells able to repopulate in patients with damaged blood vessels. Their findings, recently published in Circulation, could lead to new therapies for people with ...
May 7, 2024
0
11
Whether it's brewing a cup of coffee at home, ordering a specialty $6 latte from a local coffee shop or cracking open a Red Bull on the way to the gym, the consensus is clear: The prevalence of the caffeinated beverage industry ...
May 7, 2024
0
19
The anti-cancer drug abemaciclib (also known as Vernezio) has been added to the Australian Pharmaceutical Benefits Scheme (PBS) to treat certain types of breast cancer.
May 7, 2024
0
0
